Discontinuation report NAPROSYN
| Report ID | 232646 |
| Drug Identification Number | 02162415 |
| Brand name | NAPROSYN |
| Common or Proper name | Naproxen enteric-coated Tablets |
| Company Name | ATNAHS PHARMA UK LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NAPROXEN |
| Strength(s) | 375MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL ORAL |
| Packaging size | 100s |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-07-31 |
| Remaining supply date | 2024-07-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Discontinued by manufacturer |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SOVEREIGN HOUSE, MILES GRAY ROAD BASILDON, ESSEX GREAT BRITAIN SS14 3FR |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2024-07-10 | English | Compare |
| v2 | 2024-07-10 | French | Compare |
| v3 | 2024-08-01 | English | Compare |
Showing 1 to 3 of 3